A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2011
11/23/2011	EP2387408A1 Energetic nutritional composition comprising a laxative, electrolytes and carbohydrates
11/23/2011	EP2387407A1 Medicament for the treatment of pain and inflammation
11/23/2011	EP2387406A1 Postprandial hyperglycemia-improving agent
11/23/2011	EP2387405A2 Pirenzepine as an agent in cancer treatment
11/23/2011	EP2387404A2 Sgc stimulators of sgc activators in combination with pde5 inhbitors for the treatment of erectile dysfunction
11/23/2011	EP2387403A1 Method of treating cancer
11/23/2011	EP2387402A2 Methods for treating inflammatory disorders using 2,4-pyrimidinediamine compounds
11/23/2011	EP2387401A1 Method for treating colorectal cancer
11/23/2011	EP2387400A1 Novel forms of bendamustine free base
11/23/2011	EP2387399A2 Food supplement for the treatment of neuropathies
11/23/2011	EP2387398A1 Fulvic acid in combination with fluconazole or amphotericin b for the treatment of fungal infections
11/23/2011	EP2387397A2 Methods for identifying patients who will respond well to cancer treatment
11/23/2011	EP2387396A1 Agent for preventing and treating pityriasis versicolor
11/23/2011	EP2387395A1 Axl inhibitors for use in combination therapy for preventing, treating or managing metastatic cancer
11/23/2011	EP2387394A2 Transdermal administration of tamsulosin
11/23/2011	EP2387392A1 Pharmaceutical formulations of olmesartan
11/23/2011	EP2387390A2 Hylauronic acid containing compositions for treatment of wounds, scars, post-surgical adhesion formation
11/23/2011	EP2387389A1 Formulation for oral transmucosal administration of analgesic and/or antispasmodic molecules
11/23/2011	EP2387388A1 Sprm pharmaceutical compositions methods of treatment using them
11/23/2011	EP2387316A1 Fused amino pyridines for the treatment of brain tumors
11/23/2011	EP2387315A1 IMIDAZO[1,2-a]PYRIDINES AND IMIDAZO[1,2-b]PYRIDAZINES AS MARK INHIBITORS
11/23/2011	EP2377926A9 Chondrocyte-like cell, and method for producing same
11/23/2011	EP2306990B1 Pharmaceutical composition comprising n-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2- dihydro-2-oxo-3h-indol-3-ylidene)methyl]-2,4-dimethyl-1 h-pyrrole-3-carboxamide
11/23/2011	EP2293791B1 Pharmaceutical compositions of entacapone co-micronized with sugar alcohols
11/23/2011	EP2283011B1 2-phenyl-4-cyclopropyl-pyrimidine derivatives
11/23/2011	EP2260033B1 2-benzoylimidazo[1,2-a]pyridine derivatives, preparation thereof and therapeutic use thereof
11/23/2011	EP2222299B1 Use of levocabastine for modulating generation of pro-inflammatory cytokines
11/23/2011	EP2215058B1 Substituted n-phenyl-bipyrrolidine ureas and therapeutic use thereof
11/23/2011	EP2194981B1 Bisbenzimidazoles as antimalarial agents
11/23/2011	EP2152691B1 An improved process for preparing an optically active proton pump inhibitor
11/23/2011	EP2148670B1 Titration of tapentadol
11/23/2011	EP2127667B1 Oral disinfectant and food additive comprising the disinfectant
11/23/2011	EP2107906B1 Novel therapeutic use for treating leukaemia
11/23/2011	EP2104736B1 Mir-126 regulated genes and pathways as targets for therapeutic intervention
11/23/2011	EP2065377B1 Pyridine derivative substituted by heteroaryl ring, and antifungal agent comprising the same
11/23/2011	EP2035391B1 Indazole derivatives for treating hsp90-induced diseases
11/23/2011	EP2035008B1 Compositions and methods for preventing or reducing postoperative ileus and gastric stasis in mammals
11/23/2011	EP2021797B1 Compositions of n-ý2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl¨-1,4-dihydro-4-oxoquinoline-3-carboxamide
11/23/2011	EP2020996B1 Method and compositions for treating hematological malignancies
11/23/2011	EP2007732B1 Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases
11/23/2011	EP2004576B1 New method for the manufacture of therapeutic compounds and compositions, compounds and compositions produced therewhith, and their use
11/23/2011	EP1988902B1 Piperazine derivatives
11/23/2011	EP1973407B1 Spiro compounds and methods of use
11/23/2011	EP1951674B1 Sulfonamide derivatives and use thereof for the modulation of metalloproteinases
11/23/2011	EP1943221B1 Piperazine amidines as antiviral agents
11/23/2011	EP1937259B1 Hexahydro-cycloheptapyrazole cannabinoid modulators
11/23/2011	EP1928236B1 Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors
11/23/2011	EP1927353B1 Remedy for corneal diseases
11/23/2011	EP1915140B1 Novel use of peptide compounds for treating muscle pain
11/23/2011	EP1904048B1 Glepp-1 inhibitors in the treatment of autoimmune and/or inflammatory disorders
11/23/2011	EP1864659B1 Lignane compound-containing oil-in-water emulsion and composition comprising the same
11/23/2011	EP1852433B1 Carbazole derivative, solvate thereof, or pharmaceutically acceptable salt thereof
11/23/2011	EP1819700B1 Potassium salt of an hiv integrase inhibitor
11/23/2011	EP1802571B1 Method and intermediates for the preparation of derivatives of n-(1-benzhydryl-azetidin-3-yl)-n-phenyl-methylsulphonamide
11/23/2011	EP1765328B1 Anti-cancer composition comprising proline or its derivatives and an anti-tumour antibody
11/23/2011	EP1735277B1 2-alkylidene-18,19-dinor-vitamin d compounds
11/23/2011	EP1716868B1 Anti-inflammatory analgesic for external use
11/23/2011	EP1671649B1 Dipeptidyl peptidase IV inhibitors for treating diabetic patients with sulfonylurea secondary failure
11/23/2011	EP1651653B1 Novel cyano thiazolides, methods for the production thereof, and use thereof as a medicament
11/23/2011	EP1633375B1 Combination consisting of a magnesium preparation having a prolonged release and of certain plant extracts, and use thereof in the fields of cosmetics, therapeutics and/or nutrition
11/23/2011	EP1603553B1 Pharmaceutical compositions of cetp inhibitors
11/23/2011	EP1592786B1 Diagnosis and treatment of multiple sulfatase deficiency and other using a formylglycine generating enzyme (fge)
11/23/2011	EP1589964B1 Compounds having anti-proliferative properties
11/23/2011	EP1569937B1 C-6 modified indazolylpyrrolotriazines
11/23/2011	EP1492780B1 5-substituted 1,1-dioxo-¬1,2,5 thiazolidine-3-one derivatives as ptpase 1b inhibitors
11/23/2011	EP1467976B1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
11/23/2011	EP1391451B1 2-iminopyrrolidine derivates
11/23/2011	EP1389133B1 Methods for inactivating viruses
11/23/2011	EP1385527B2 Use of 2-alpha-cyano-4-alpha, 5-alpha-epoxyandrostan-17-beta-ol-3-one derivatives for lowering levels of serum cortisol and for the treatment of clinical conditions associated thereof
11/23/2011	EP1226148B1 Novel oligosaccharides, preparation method and pharmaceutical compositions containing same
11/23/2011	EP1137439B2 Stabilization of rapamycins or derivatives of rapamycins
11/23/2011	EP1087779B1 Compositions for increasing energy in vivo
11/23/2011	CN1980673B A method for the prevention of thromboembolic disorders
11/23/2011	CN1973884B Bobei throat-fitting buccal tablet
11/23/2011	CN1968921B Glucagon receptor antagonists, preparation and therapeutic uses
11/23/2011	CN1929815B Compositions comprising mannose phosphate for vaginal treatment
11/23/2011	CN1907954B Water-soluble derivative of anesthetic 2,6-diisopropyl phenol and preparation method thereof
11/23/2011	CN1897973B Application of lactoferrin and polyinosinicacid in proliferation agent combinations of preparation of animal nature killer cells
11/23/2011	CN1706847B Process for preparing 10alpha-[4'-(s,s-dioxothiomorpholin-1'-yl)]-10-deoxo-10-dihydroartemisinin
11/23/2011	CN1691947B Application of treating or preventing immune mediated disorders and pharmaceutical formulation for use therein
11/23/2011	CN1671351B NSAID-containing topical formulations that demonstrate chemopreventive activity
11/23/2011	CN102257140A Treating hepatitis c virus infection with over-expression of microrna-196
11/23/2011	CN102257133A Chondrocyte-like cell, and method for producing same
11/23/2011	CN102257011A Production of a saccharide composition comprising glucans and mannans by alkaline and acid hydrolysis of yeast cells
11/23/2011	CN102256991A Uracyl cyclopropyl nucleotides
11/23/2011	CN102256990A Anionic oligosaccharide conjugates
11/23/2011	CN102256989A Anionic conjugates of glycosylated bacterial metabolite
11/23/2011	CN102256984A Method for producing diamine derivative
11/23/2011	CN102256983A Spiro-oxindole compounds and their use as therapeutic agents
11/23/2011	CN102256980A 3-(3-pyrimidin-2-yl-benzyl)-[1,2,4]triazolo[4,3-b]pyrimidine derivatives
11/23/2011	CN102256979A Derivatives of 6-cycloamino-2-thienyl-3-(pyridin-4-yl)imidazo[1,2-b]-pyridazine and 6-cycloamino-2-furanyl-3-(pyridin-4-yl)imidazo[1,2-b]-pyridazine, preparation and therapeutic application thereof
11/23/2011	CN102256977A Purine compounds
11/23/2011	CN102256975A Novel polymorphic forms of an azabicyclo-trifluoromethyl benzamide derivative
11/23/2011	CN102256974A Substituted bicyclic imidazole derivatives as gamma secretase modulators
11/23/2011	CN102256973A Corydaline derivatives useful for reducing lipid levels
11/23/2011	CN102256972A Thiazolyl-benzimidazoles
11/23/2011	CN102256970A Compositions and methods for treatment of renin-angiotensin aldosterone system (raas)-related disorders
11/23/2011	CN102256969A Compounds that modulate intracellular calcium
11/23/2011	CN102256968A Heterocyclic antiviral compounds
11/23/2011	CN102256966A Soluble mtor complexes and modulators thereof

1 ... 1470 1471 1472 1473 1474 1475 1476 1477 1478 1479 1480 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 ... 7860